agilon health, inc. (AGL) research

agilon health, inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Medical Care Facilities
Last price
$84.28
As of

Kresmion compiles this page from AGL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

agilon health, inc. (AGL): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-05.

As of . Source: SEC EDGAR filings for AGL. Method and limitations.

SHARE THIS CARD

Share the AGL intelligence card

A branded snapshot of AGL: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion AGL intelligence card preview
Post to X
COMPANY DOSSIER

See the full AGL dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for AGL on one page. Preview it with sample data, then open it live with a free account.

Preview the AGL dossier

Active signals for AGL

FREE, NO ACCOUNT

Every signal on AGL, as it fires

You are seeing 5 of 14 signals recorded on AGL since 2026-06-21.

The five above landed across 2 days. The other 9 were recorded on 2 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in AGL (2026Q2)

Manager / securityMarket value% portfolioQoQ
D. E. Shaw & Co., Inc.CUSIP 00857U206 · 2026Q2$41.8M0.02%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 00857U206 · 2026Q2$16.3M0.02%,
TWO SIGMA INVESTMENTS, LPCUSIP 00857U206 · 2026Q2$13.5M0.01%,
CITADEL ADVISORS LLCCUSIP 00857U206 · 2026Q2$6M0.00%,
MILLENNIUM MANAGEMENT LLCCUSIP 00857U206 · 2026Q2$3.6M0.00%,
Point72 Asset Management, L.P.CUSIP 00857U206 · 2026Q2$3.5M0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, AGL

AGL against its peers

AGL's operating margin of -7.8% ranks in the 9th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.

MetricAGLPeer medianPercentilen
Revenue FY5.9B USD1.4B USD8617
Gross marginn/a23.0%n/a5
Operating margin-7.8%3.7%916
Net margin-6.6%2.8%1818
Return on equity-308.8%8.8%315
P / En/a24.7xn/a10

Peers (18): ARDT, INNV, NUTX, ASTH, SNDA, SGRY, ADUS, GRDN, TOI, NHC, MCTA, SRTA, LFST, CON, CYH, FMS, AIRS, JYNT. Left out: LTGHY (no annual filing), GMRS (no annual filing), BUHPY (no annual filing), AUNA (no annual filing), HWAIF (no annual filing), WW (no annual filing), PARK (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (AGL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Follow AGL on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to AGL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the AGL dossier